Immunomic Therapeutics Appoints Harvard’s Brain Tumor Expert, Dr. E. Antonio Chiocca, to its Scientific Advisory Board

Published on : September 17, 2019September 17, 2019 Published by : Chris Frew

Immunomic Therapeutics Appoints Harvard’s Brain Tumor Expert, Dr. E. Antonio Chiocca, to its Scientific Advisory Board ROCKVILLE, Md.–(BUSINESS WIRE)– Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that it has appointed brain tumor expert E. Antonio ‘Nino’ Chiocca, M.D., Ph.D., Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School Neurosurgeon-in-Chief and [….]

CRB Welcomes Jacob Greenwood as Director of Business Development

Published on : September 17, 2019September 17, 2019 Published by : Chris Frew

CRB Welcomes Jacob Greenwood as Director of Business Development Rockville, MD – September 3, 2019 – CRB is excited to welcome Jacob Greenwood as Director of Business Development in the Maryland office. Greenwood has twelve years’ experience in the biotechnology field, as well as a background in marketing and sales, technical services, and facility/program management. [….]

Welldoc Welcomes Dan Medin, VP of Market Solution to the Team.

Published on : September 5, 2019September 6, 2019 Published by : Chris Frew

Welldoc Welcomes Dan Medin, VP of Market Solution to the Team. Welldoc is excited to welcome Dan Medin, VP of market solution to the team. Dan brings a wealth of industry experience. We’re happy to have him on board as we expand the BlueStar community. Original Post

Vaccitech Appoints Bill Enright as New Chief Executive Officer

Published on : August 28, 2019August 28, 2019 Published by : Chris Frew

Vaccitech Appoints Bill Enright as New Chief Executive Officer OXFORD, UK, August 27, 2019 / B3C newswire / — Vaccitech, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases (ID), announced today that it has appointed Bill Enright as its new Chief Executive Officer (CEO). Mr. Enright succeeds Tom [….]

Ceres Nanosciences, Inc. announces New Head of Sales

Published on : August 14, 2019August 14, 2019 Published by : Chris Frew

Ceres Nanosciences, Inc. announces New Head of Sales Ceres is very excited to announce that Tara Jones-Roe has joined Ceres as the head of sales. She comes to Ceres with nearly 20 years of experience in the diagnostics and life sciences industry at Molecular Devices, Beckman Coulter, Thermo Fisher Scientific, and Roche Diagnostics. Tara brings [….]

FACILITY LOGIX WELCOMES TWO NEW ASSOCIATE PROJECT MANAGERS TO BOLSTER PROJECT TEAMS

Published on : August 5, 2019August 5, 2019 Published by : Chris Frew

Facility Logix Welcomes Two New Associate Project Managers to Bolster Project Teams Burtonsville, MD – August 1, 2019 – Facility Logix, a leading life science consulting firm, has hired two new Associate Project Managers: Jocaro L. Dodd and Wayne Mitchell. The new Associate Project Managers will be instrumental in addressing the facility-related needs of the firm’s [….]

CRB Announces the Promotion of Ben Skowronski to the Leader of the Maryland office

Published on : July 30, 2019July 30, 2019 Published by : Chris Frew

CRB Announces the Promotion of Ben Skowronski to the Leader of the Maryland office CRB is excited to announce the promotion of Ben Skowronski to the leader of the Maryland office. Skowronski has demonstrated strong leadership and business development skills in the architecture, engineering and construction industries in the Northeast for 15 years and has [….]

MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform

Published on : July 23, 2019July 23, 2019 Published by : Chris Frew

MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform Dhana Chinnasamy, PhD, will oversee non-clinical and translational activities for MaxCyte’s autologous cell therapy platform for targeted cell-based immune therapies GAITHERSBURG, Md., July 23, 2019 /PRNewswire/ — MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announced today that it [….]

Immunomic Therapeutics Appoints Andrew Eisen, M.D., Ph.D. As VP, Clinical Development

Published on : July 17, 2019July 17, 2019 Published by : Chris Frew

Immunomic Therapeutics Appoints Andrew Eisen, M.D., Ph.D. As VP, Clinical Development ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the appointment of Andrew Eisen, M.D., Ph.D. as VP, Clinical Development. Dr. Eisen is a translational medicine and clinical development specialist with over 20 years of experience in the biotech [….]

BrainScope Advances its Commercial Adoption and Appoints Industry Veteran Susan Hertzberg as CEO

Published on : June 25, 2019June 25, 2019 Published by : Chris Frew

BETHESDA, MD. June 24, 2019 – BrainScope announced today the appointment of Susan Hertzberg as Chief Executive Officer. This is the 4th equity-backed venture that Hertzberg will helm. She is a proven commercial stage leader with an impressive track record of bringing innovative products and services to market and profitably scaling and delivering exceptional market [….]